Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2016
Reply to M.A.N. Şendur et al and J. Michels
David F Penson, Andrew J Armstrong, Raoul Concepcion, et al.
Prostate Cancer and Prostatic Diseases
|
September 5, 2024
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing
Lauren Lenz, Wyatt Clegg, Diana Iliev, et al.
BJUI Compass
|
March 14, 2024
Optilume drug-coated balloon for anterior urethral stricture: 2-year results of the ROBUST III trial
Maia E VanDyke, Allen F Morey, Karl Coutinho, et al.
The Journal of Urology
|
December 2, 2021
One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume<sup>®</sup> Drug-Coated Balloon for Anterior Urethral Strictures
Sean P Elliott, Karl Coutinho, Kaiser J Robertson, et al.
The Journal of Urology
|
December 29, 2021
Reply by Authors
Sean P Elliott, Karl Coutinho, Kaiser J Robertson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 5, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation
Jonathan Tward, Lauren Lenz, Darl D Flake, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2016
Reply to M.A.N. Şendur et al and J. Michels
David F Penson, Andrew J Armstrong, Raoul Concepcion, et al.
Prostate Cancer and Prostatic Diseases
|
September 5, 2024
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing
Lauren Lenz, Wyatt Clegg, Diana Iliev, et al.
BJUI Compass
|
March 14, 2024
Optilume drug-coated balloon for anterior urethral stricture: 2-year results of the ROBUST III trial
Maia E VanDyke, Allen F Morey, Karl Coutinho, et al.
The Journal of Urology
|
December 2, 2021
One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume<sup>®</sup> Drug-Coated Balloon for Anterior Urethral Strictures
Sean P Elliott, Karl Coutinho, Kaiser J Robertson, et al.
The Journal of Urology
|
December 29, 2021
Reply by Authors
Sean P Elliott, Karl Coutinho, Kaiser J Robertson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 5, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation
Jonathan Tward, Lauren Lenz, Darl D Flake, et al.
Page
of 2